Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs

Vaccine

Volumn 19, Issue 11-12, 2001, Pages 1467-1476

  De Smit, A J ^a   Bouma, A ^a   Van Gennip, H G P ^a   De Kluijver, E P ^a   Moormann, R J M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Classical swine fever; Marker vaccines; Recombinant virus

Indexed keywords

CEDIPEST; FLC11 VACCINE; FLC9 VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SCREENING; INFECTION PREVENTION; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SWINE DISEASE; VACCINATION; VIRUS INFECTION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; CHIMERA; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; GENETIC MARKERS; SWINE; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRULENCE;

EID: 0035825105     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00347-9     Document Type: Article

References (39)

1. The universal system of virus taxonomy, updated to include the new proposals ratified by the International Committee on Taxonomy of Viruses during 1998
2. Hog cholera
3. Control of swine fever in enzootic areas by regional vaccination for limited periods using C-strain virus
4. Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain
5. Assessment of safety and protective value of a cell culture modified strain 'C' vaccine of hog cholera/classical swine fever virus
6. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera
7. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus
8. Classical swine fever virus (CSFV) envelope gylcoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge
9. An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV)
10. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera
11. Structural proteins of hog cholera virus expressed by vaccinia virus: Further characterization and induction of protective immunity
12. Classical swine fever virus: Independent induction of protective immunity by two structural glycoproteins
13. Comparison of the protective efficacy of recombinant pseudorabies viruses against pseudorabies and classical swine fever in pigs: Influence of different promotors on gene expression and on protection
14. Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever
15. Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever
16. Infectious RNA transcribed from an engineered full length cDNA template of the genome of a pestivirus
17. Classical swine fever virus: Recovery of infectious viruses from cDNA constructs and generation of recombinant cytopathogenic defective interfering particles
18. Mutations abrogating the RNase activity in glycoprotein E-rns of the pestivirus classical swine fever virus lead to virus attenuation
19. Attitude of the European community to vaccines
20. Potency control of modified live viral vaccines for veterinary use
21. Sub-clinical swine fever: A survey of neutralizing antibodies in the sera of pigs from herds having reproductive failures
22. The protective value of vaccine induced neutralizing antibody titres in swine fever
23. Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis
24. A simple method of estimating fifty percent end points
25. Studies on the pathogenesis of Hog Cholera. I. Demonstration of hog cholera virus subsequent to oral exposure
26. An improved ELISA for the detection of serum antibodies directed against classical swine fever virus
27. The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus
28. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against Classical Swine Fever virus
29. Characterization of porcine and some ruminant pestiviruses by cross-neutralization
30. Six antigenic groups within the genus pestivirus as identified by cross neutralization assays
31. Inhibition of virus replication in the tonsils of pigs previously vaccinated with a Chinese strain vaccine and challenged oronasally with a virulent strain of classical swine fever virus
32. Prevention of transplacental transmission of moderate-virulent classical swine fever (CSF) virus after a single or double vaccination with a CSF E2 subunit vaccine
33. Pseudorabies is massively transmitted among vaccinated conventional pigs, but not among vaccinated SPF pigs
34. Influence of breed-related factors on the course of classical swine fever virus infection